ATE136776T1 - Verwendung von heptastigmin zur behandlung der zerebralen ictus - Google Patents

Verwendung von heptastigmin zur behandlung der zerebralen ictus

Info

Publication number: ATE136776T1
Authority: AT; Austria
Prior art keywords: heptastigmine; treat cerebral; ictus; cerebral ictus; treat
Prior art date: 1990-12-21

Application number

AT91121676T

Other languages

English (en)

Inventor

Bono Rinaldo Del

Bruno Pietro Imbimbo

Original Assignee

Mediolanum Farmaceutici Srl

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1990-12-21

Filing date

1991-12-18

Publication date

1996-05-15

1991-12-18 Application filed by Mediolanum Farmaceutici Srl filed Critical Mediolanum Farmaceutici Srl

1996-05-15 Application granted granted Critical

1996-05-15 Publication of ATE136776T1 publication Critical patent/ATE136776T1/de

Links

RRGMXBQMCUKRLH-CTNGQTDRSA-N [(3ar,8bs)-3,4,8b-trimethyl-2,3a-dihydro-1h-pyrrolo[2,3-b]indol-7-yl] n-heptylcarbamate Chemical compound C12=CC(OC(=O)NCCCCCCC)=CC=C2N(C)[C@@H]2[C@@]1(C)CCN2C RRGMXBQMCUKRLH-CTNGQTDRSA-N 0.000 title abstract 2
230000002490 cerebral effect Effects 0.000 title abstract 2
230000003727 cerebral blood flow Effects 0.000 abstract 1
239000008194 pharmaceutical composition Substances 0.000 abstract 1
230000001225 therapeutic effect Effects 0.000 abstract 1

Classifications

- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/13—Amines
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/08—Vasodilators for multiple indications
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis

Landscapes

Health & Medical Sciences (AREA)
Animal Behavior & Ethology (AREA)
Public Health (AREA)
Pharmacology & Pharmacy (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Veterinary Medicine (AREA)
Engineering & Computer Science (AREA)
Chemical Kinetics & Catalysis (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
General Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Neurology (AREA)
Heart & Thoracic Surgery (AREA)
Neurosurgery (AREA)
Cardiology (AREA)
Biomedical Technology (AREA)
Epidemiology (AREA)
Hospice & Palliative Care (AREA)
Psychiatry (AREA)
Urology & Nephrology (AREA)
Vascular Medicine (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Nitrogen Condensed Heterocyclic Rings (AREA)
Steroid Compounds (AREA)
Medicines Containing Plant Substances (AREA)
Magnetic Resonance Imaging Apparatus (AREA)

AT91121676T 1990-12-21 1991-12-18 Verwendung von heptastigmin zur behandlung der zerebralen ictus ATE136776T1 (de)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
IT02251390A IT1246050B (it)	1990-12-21	1990-12-21	Impiego dell'eptastigmina nella terapia dell'ictus cerebrale.

Publications (1)

Publication Number	Publication Date
ATE136776T1 true ATE136776T1 (de)	1996-05-15

Family

ID=11197279

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
AT91121676T ATE136776T1 (de)	1990-12-21	1991-12-18	Verwendung von heptastigmin zur behandlung der zerebralen ictus

Country Status (9)

Country	Link
EP (1)	EP0492383B1 (de)
JP (1)	JPH04308529A (de)
KR (1)	KR920011482A (de)
AT (1)	ATE136776T1 (de)
CA (1)	CA2058228A1 (de)
DE (1)	DE69118847T2 (de)
ES (1)	ES2085411T3 (de)
IE (1)	IE914463A1 (de)
IT (1)	IT1246050B (de)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
KR100908068B1 (ko) *	2008-12-31	2009-07-15	주식회사 비케이티	대리석 석판, 대리석 석판 가공장치 및 그 가공방법

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
IT1199076B (it) *	1984-03-01	1988-12-30	Consiglio Nazionale Ricerche	Derivati della fisostigmina con proprieta'di inibizione della aceticolinesterasi e relativo procedimento di produzione

1990
- 1990-12-21 IT IT02251390A patent/IT1246050B/it active IP Right Grant
1991
- 1991-12-18 DE DE69118847T patent/DE69118847T2/de not_active Expired - Fee Related
- 1991-12-18 ES ES91121676T patent/ES2085411T3/es not_active Expired - Lifetime
- 1991-12-18 AT AT91121676T patent/ATE136776T1/de active
- 1991-12-18 EP EP91121676A patent/EP0492383B1/de not_active Expired - Lifetime
- 1991-12-19 IE IE446391A patent/IE914463A1/en not_active Application Discontinuation
- 1991-12-20 CA CA002058228A patent/CA2058228A1/en not_active Abandoned
- 1991-12-20 JP JP3354447A patent/JPH04308529A/ja active Pending
- 1991-12-20 KR KR1019910023605A patent/KR920011482A/ko not_active Withdrawn

Also Published As

Publication number	Publication date
EP0492383A1 (de)	1992-07-01
IT9022513A0 (it)	1990-12-21
KR920011482A (ko)	1992-07-24
EP0492383B1 (de)	1996-04-17
IE914463A1 (en)	1992-07-01
IT9022513A1 (it)	1992-06-21
IT1246050B (it)	1994-11-07
DE69118847D1 (de)	1996-05-23
ES2085411T3 (es)	1996-06-01
CA2058228A1 (en)	1992-06-22
JPH04308529A (ja)	1992-10-30
DE69118847T2 (de)	1996-09-05

Similar Documents

Publication	Publication Date	Title
ATE184792T1 (de)	1999-10-15	2-bromomelatonin zur behandlung von schlafstörungen
DE3684190D1 (de)	1992-04-16	Verwendung von tetrahydrobiopterinen zur herstellung eines medikaments zur behandlung von kinderautismus.
DE3856594D1 (de)	2008-11-27	Mittel zur behandlung der alzheimer-krankheit
ATE254926T1 (de)	2003-12-15	Verwendung eines consensus-interferons zur reduzierung der nebeneffekte in der interferon behandlung von viralen hepatiten.
BG60253B1 (bg)	1994-03-24	Човешки тъканен плазминогенен активатор
DE69124293D1 (de)	1997-03-06	Vorrichtung zur Behandlung von Wirbelsäulenerkrankungen
DE58902094D1 (de)	1992-10-01	Kombinationspraeparat zur behandlung von nervenzell-und nervenfasererkrankungen und verletzungen.
DE3582439D1 (de)	1991-05-16	Mittel zur behandlung von herzerkrankungen.
ATE137965T1 (de)	1996-06-15	Verwendung von tomoxetine zur behandlung von funktionsstörungen der niedrigen harnwege
ATE174798T1 (de)	1999-01-15	Die herstellung von zusammensetzungen zur behandlung von krankheiten der zellproliferation
DE3854121D1 (de)	1995-08-10	Arzneimittelzusammensetzungen zur behandlung von psoriasis.
ATE106736T1 (de)	1994-06-15	Verwendung von dimethylpolysiloxan zur behandlung von erkrankungen des gastrointestinaltraktes.
ATE89737T1 (de)	1993-06-15	Behandlung von leukozytstoerungen mit gm-csf.
DE69431199D1 (de)	2002-09-26	Melatonin-Derivate zur Verwendung in der Behandlung von Schlafstörungen
ATE239470T1 (de)	2003-05-15	Melatonin-derivate zur verwendung in der behandlung von desynchronisierungs-erkankungen
ATE74762T1 (de)	1992-05-15	Pharmazeutisches praeparat zur behandlung von stoerungen des fettstoffwechsels (hyperlipoproteinaemien).
DE69313261D1 (de)	1997-09-25	Verwendung von LACTOFERRIN zur Herstellung eines THERAPEUTISCHEN MITTELS zur Behandlung von RHEUMATISMUS
ATE59780T1 (de)	1991-01-15	Pharmazeutische zusammensetzung zur behandlung von tumoren.
ATE5256T1 (de)	1983-11-15	Phenylpiperazinderivate von 1,3,4oxadiazolylphenolen, ihre herstellung und diese enthaltende therapeutische mittel.
ATE45675T1 (de)	1989-09-15	Verwendung von interferon gamma (ifn-gamma) zur herstellung von praeparationen zur behandlung rheumatischer erkrankungen.
DE69118847D1 (de)	1996-05-23	Verwendung von Heptastigmin zur Behandlung der zerebralen Ictus
ATE69949T1 (de)	1991-12-15	Liposomen mit inhalativen allergenen zur behandlung von allergien, verfahren zu ihrer herstellung und diese enthaltende arzneimittel.
DE3775278D1 (de)	1992-01-30	Topische methotrexatzubereitung zur behandlung hyperproliferativer epithelerkrankungen.
ATE229343T1 (de)	2002-12-15	Kombination von temozolomide und alpha-interferon zur behandlung von fortgeschrittenem krebs
DE59410340D1 (de)	2004-01-15	Verwendung von Bradykinin-Antagonisten zur Behandlung von Viruserkrankungen